Cleared Special

K230625 - ReliOn Premier BLU Blood Glucose Monito...

K230625 is the FDA 510(k) clearance for ReliOn Premier BLU Blood Glucose Monito... by I-Sens, Inc.. It is a Class 2 Chemistry device (product code NBW) cleared through the Special 510(k) pathway after a 157-day FDA review.

K230625 · I-Sens, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
157d
Days
Class 2
Risk

K230625 is an FDA 510(k) clearance for the ReliOn Premier BLU Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by I-Sens, Inc. (Seoul, KR). The FDA issued a Cleared decision on August 10, 2023 after a review of 157 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all I-Sens, Inc. devices

Submission Details

510(k) Number K230625 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2023
Decision Date August 10, 2023
Days to Decision 157 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d slower than avg
Panel avg: 88d · This submission: 157d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 235
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K230625.
VivaChek Link Plus Blood Glucose Monitoring System
K233058 · Vivachek Biotech (Hangzhou) Co., Ltd. · Dec 2023
TRUENESS™ AIR Blood Glucose Monitoring System
K231476 · Sinocare, Inc. · Dec 2023
Accu-Chek Guide Solo diabetes manager blood glucose monitoring system
K213131 · Roche Diabetes Care GmbH · Aug 2023
MIO Blood Glucose Monitoring System
K223722 · Mio Labs, Inc. · Jun 2023
GlucoSure ADVANCE Link Blood Glucose Monitoring System
K222234 · Apex BioTechnology Corp. · Dec 2022
CONTOUR® NEXT GEN Blood Glucose Monitoring System
K223293 · Ascensia Diabetes Care U.S., Inc. · Nov 2022